Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Intraepithelial Lesions 1 Muscle Invasive Bladder Cancer (MIBC) 1 Limited Stage Small Cell Lung Cancer 1 Helicobacter Infections 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 11 Cisplatin 6 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Specimen Handling 4 Radiotherapy 4 Radiation 4 Mitomycin 4 Paclitaxel 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Cetuximab 3 Carboplatin 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Platinum 2 Mitozytrex 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 tislelizumab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡